<?xml version="1.0" encoding="UTF-8"?>
<p id="p0130">Inflammation is a response of the body defense system against infections and tissue damage (
 <xref rid="bib65" ref-type="bibr">Punchard et al., 2004</xref>). Adverse effects associated with non-steroidal anti-inflammatory drugs (NSAIDs) arouse the need to develop safe alternatives for the treatment of chronic inflammations (
 <xref rid="bib77" ref-type="bibr">Sostres et al., 2010</xref>). Hispolon induces potent anti-inflammatory response by suppressing TNF-α (tumor necrosis factor-α) (
 <xref rid="bib56" ref-type="bibr">Lin et al., 2014</xref>), and decreasing MMP-9 
 <italic>via</italic> inhibition of NF-κB pathway (
 <xref rid="bib80" ref-type="bibr">Sun et al., 2015</xref>). Anti-inflammatory actions of hispolon occur 
 <italic>via</italic> inhibition of JNK phosphorylation (
 <xref rid="bib93" ref-type="bibr">Yang et al., 2014</xref>). Hispolon possesses inhibitory activity against LPS-induced inflammation 
 <italic>via</italic> inhibiting JNK and NF-kB while upregulating HO-1 (Heme oxygenase-1) protein in BV-2 cells (
 <xref rid="bib90" ref-type="bibr">Wu et al., 2017</xref>).
</p>
